Showing results (3971-3980 of 6,511) with videos related to
Sort By:
Pageof 652
Experimental Hematology|December 9, 1998
In vitro and in vivo hematopoietic activities of Betafectin PGG-glucanM L Patchen, T Vaudrain, H Correira, et al.Experimental Hematology|October 1, 1996
Optimal processing of human umbilical cord blood for clinical bankingP Denning-Kendall, C Donaldson, A Nicol, et al.Experimental Hematology|October 1, 1996
HLA class II signaling mediates cellular activation and programmed cell deathJ P Truman, F Garban, C Choqueux, et al.Experimental Hematology|October 1, 1996
Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strainM Kitagawa, S Aizawa, H Kamisaku, et al.Experimental Hematology|January 1, 1977
Factors affecting erythroid colony growth (CFU-E) from human marrowM H Freedman, E F SaundersExperimental Hematology|January 1, 1977
The interaction of erythropoietin with fetal liver cells. I. Measurement of proliferation by tritiated thymidine incorporationT N Fredrickson, K A Smith, C J Cornell, et al.Experimental Hematology|September 1, 1991
Dibutyryl cyclic AMP induces formyl peptide receptor expression and chemotactic responses in a human eosinophilic cell line, EoL-1Y Uenoyama, Y Ohshima, M Morita, et al.Experimental Hematology|August 1, 1980
Mechanism underlying the inhibitory effect of dexamethasone on in vivo erythropoiesisM J Giglio, R M Alippi, C E BozziniExperimental Hematology|August 1, 1980
Regulation of erythropoiesis in diabetes mellitusC D Dunn, W Law, R B Andrews, et al.Experimental Hematology|January 9, 2008
Requirement for p85alpha regulatory subunit of class IA PI3K in myeloproliferative disease driven by an activation loop mutant of KITVeerendra Munugalavadla, Emily C Sims, Rebecca J Chan, et al.Pageof 652